Reinhardt et al. defined a novel methylation class, high grade astrocytoma with piloid featured (HGAP), characterized by MAPK pathway activation, CDKN2A/B deletions, and ATRX mutations [6]. Here, CDKN2A is linked to astrocytoma (excluding glioblastoma).